Effectiveness of the Q fever vaccine: A meta-analysis

Vaccine

Volumn 29, Issue 3, 2011, Pages 395-398

  Gefenaite, G ^a,b   Munster, J M ^a,b   van Houdt, R ^c   Hak, E ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c Health Council of the Netherlands   (Netherlands)

Author keywords

Effectiveness; Q fever; Vaccination

Indexed keywords

Q FEVER VACCINE;

DRUG EFFICACY; HEALTH CARE PERSONNEL; HUMAN; INCUBATION TIME; MANTEL HAENSZEL TEST; META ANALYSIS; PRIORITY JOURNAL; Q FEVER; REVIEW; VACCINATION;

BACTERIAL VACCINES; HUMANS; NETHERLANDS; Q FEVER; TREATMENT OUTCOME;

EID: 78650519317     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.11.008     Document Type: Review

References (17)

1. van der Hoek W., Dijkstra F., Schimmer B., Schneeberger P.M., Vellema P., Wijkmans C., et al. Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill 2010, 15(12).
2. Maurin M., Raoult D. Q fever. Clin Microbiol Rev 1999, 12(4):518-553. Oct.
3. Chiu C.K., Durrheim D.N. A review of the efficacy of human Q fever vaccine registered in Australia. N S W Public Health Bull 2007, 18(7-8):133-136. Jul.
4. Deeks J.J., Higgins J.P.T., Altman D.G. Analysing and presenting results. Cochrane Handbook for systematic reviews of interventions 4. 2. 5; section 8 2010, John Wiley & Sons, Chichester, UK. P. Alderson, S. Green, J. Higgins (Eds.).
5. Wells G.A., Shea B., O'Connell D., Peterson J., Welch V., Losos M., et al. The Newcastle-Otawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2010. URL: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
6. Rothman JK, Greenland S. Modern epidemiology. 2nd ed.; 1998.
7. Sato T. Biometrics 1989, 1323-1324.
8. Marmion B.P., Ormsbee R.A., Kyrkou M., Wright J., Worswick D.A., Cameron S., et al. Vaccine prophylaxis of abattoir-associated Q fever. Lancet 1984, 2(8417-8418):1411-1414. Dec 22.
9. Marmion B.P., Ormsbee R.A., Kyrkou M., Wright J., Worswick D.A., Izzo A.A., et al. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs. Epidemiol Infect 1990, 104(2):275-287. Apr.
10. Ackland J.R., Worswick D.A., Marmion B.P. Vaccine prophylaxis of Q fever. A follow-up study of the efficacy of Q-Vax (CSL) 1985-1990. Med J Aust 1994, 160(11):704-708. Jun 6.
11. Benenson A.S. Q fever vaccine: efficacy and present status. Symposium on Q fever ArmyMed Serv Grad School Walter Reed ArmyMed Center Med Sci Publ No 6 U S Government Printing Office 1959, 47-60. J.E. Smadel (Ed.).
12. Fiset P. Vaccination against Q fever. Proceedings of first international congress on vaccines against viral and rickettsial diseases of man 1967, 147-528. PAHO Science Publication.
13. Gilroy N., Formica N., Beers M., Egan A., Conaty S., Marmion B., Abattoir-associated Q fever: a Q fever outbreak during a Q fever vaccination program. Aust N Z J Public Health 2001, 25(4):362-367. Aug.
14. Ormsbee R.A.M.B. Prevention of Coxiella burnetii infection-vaccines and guidelines for those at risk. Q fever 1990, CRC Press, Boca Raton, Florida. T. Marrie (Ed.).
15. Shapiro R.A., Siskind V., Schofield F.D., Stallman N., Worswick D.A., Marmion B.P. A randomized, controlled, double-blind, cross-over, clinical trial of Q fever vaccine in selected Queensland abattoirs. Epidemiol Infect 1990, 104(2):267-273. Apr.
16. Gidding H.F., Wallace C., Lawrence G.L., McIntyre P.B. Australia's national Q fever vaccination program. Vaccine 2009, 27(March 23 (14)):2037-2041.
17. Leone M., Honstettre A., Lepidi H., Capo C., Bayard F., Raoult D., et al. Effect of sex on Coxiella burnetii infection: protective role of 17beta-estradiol. J Infect Dis 2004, 189(2):339-345. Jan 15.